Subgroup | N | OR | LCI | UCI | POR | Model | Phetero | I2 | Pbegg | Pegger |
---|---|---|---|---|---|---|---|---|---|---|
Overall | 9 | 3.507 | 2.194 | 5.607 | < 0.001 | F | 0.703 | 0.00% | 0.048 | 0.008 |
Control type | ||||||||||
Other temperature controls | 5 | 3.067 | 1.750 | 5.374 | < 0.001 | F | 0.387 | 3.50% | ||
Non-TH induction | 4 | 4.794 | 2.037 | 11.282 | < 0.001 | F | 0.891 | 0.00% | ||
Regions | 1 | |||||||||
Japan | 4 | 4.803 | 2.196 | 10.505 | < 0.001 | F | 0.627 | 0.00% | ||
Korea | 3 | 2.740 | 1.324 | 5.673 | 0.007 | F | 0.342 | 6.70% | ||
Sample size | 1 | |||||||||
< 80 | 4 | 4.814 | 1.873 | 12.378 | 0.001 | F | 0.438 | 0.00% | ||
≥ 80 | 5 | 3.162 | 1.841 | 5.428 | < 0.001 | F | 0.697 | 0.00% | ||
CA location | ||||||||||
Mixed | 4 | 2.828 | 1.587 | 5.039 | < 0.001 | F | 0.577 | 0.00% | ||
OHCA | 5 | 5.320 | 2.382 | 11.881 | < 0.001 | F | 0.744 | 0.00% | ||
mNOS score | 1 | |||||||||
≥ 7 | 5 | 3.456 | 1.968 | 6.070 | < 0.001 | F | 0.374 | 5.70% | ||
< 7 | 4 | 3.627 | 1.553 | 8.468 | 0.003 | F | 0.741 | 0.00% | ||
OR obtained methods | ||||||||||
U | 6 | 4.428 | 2.211 | 8.870 | < 0.001 | F | 0.699 | 0.00% | ||
M | 3 | 2.885 | 1.527 | 5.449 | 0.001 | F | 0.428 | 0.00% | ||
Follow-up | 1 | |||||||||
Discharge/30 days | 6 | 2.889 | 1.690 | 4.940 | < 0.001 | F | 0.813 | 0.00% | ||
90 days | 3 | 6.592 | 2.505 | 17.349 | < 0.001 | F | 0.573 | 0.00% |